Obesity promotes worse outcome for post-menopausal breast cancer patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
126
Cancer Therapy and Research Center at UTHSCSA
San Antonio, Texas, United States
Biomarker levels
Blood levels of Prostaglandin E2, aromatase, pro-inflammatory cytokines, steroids, and lipids will be measured pre and post treatment.
Time frame: 29 days
BMI
Correlation for body mass index impact on response to COX2 inhibition.
Time frame: 29 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.